Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio

HL Parnes, MG House, J Kagan, DJ Kausal… - The Journal of …, 2004 - Elsevier
PURPOSE: We describe the current National Cancer Institute chemoprevention agent
development program and provide a summary of the intermediate end points used …

Prostate Cancer Chemoprevention Agent Development: The National Cancer Institute, Division of Cancer Prevention Portfolio

HL PARNES, MG HOUSE, J KAGAN… - The Journal of …, 2004 - auajournals.org
Purpose: We describe the current National Cancer Institute chemoprevention agent
development program and provide a summary of the intermediate end points used …

Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.

HL Parnes, MG House, J Kagan, DJ Kausal… - The Journal of …, 2004 - europepmc.org
Purpose We describe the current National Cancer Institute chemoprevention agent
development program and provide a summary of the intermediate end points used …

[引用][C] Prostate cancer chemoprevention agent development: The National Cancer Institute, Division of Cancer Prevention portfolio

P HL - J. Urol., 2004 - cir.nii.ac.jp
Prostate cancer chemoprevention agent development : The National Cancer Institute, Division
of Cancer Prevention portfolio | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio

HL Parnes, MG House, J Kagan… - The Journal of …, 2004 - pubmed.ncbi.nlm.nih.gov
Purpose We describe the current National Cancer Institute chemoprevention agent
development program and provide a summary of the intermediate end points used …

[引用][C] Prostate cancer chemoprevention agent development: The national cancer institute, division of cancer prevention portfolio. Discussion

HL PARNES, MG HOUSE, J KAGAN… - The Journal of …, 2004 - pascal-francis.inist.fr
Prostate cancer chemoprevention agent development: The national cancer institute,
division of cancer prevention portfolio. Discussion CNRS Inist Pascal-Francis CNRS Pascal …

Prostate Cancer Chemoprevention Agent Development: The National Cancer Institute, Division of Cancer Prevention Portfolio

HL PARNES, MG HOUSE, J KAGAN, DJ KAUSAL… - The Journal of …, 2004 - infona.pl
We describe the current National Cancer Institute chemoprevention agent development
program and provide a summary of the intermediate end points used. The National Cancer …

[引用][C] Prostate cancer chemoprevention agent development: The national cancer institute, division of cancer prevention portfolio. Discussion

HL PARNES, MG HOUSE, J KAGAN, DJ KAUSAL… - The Journal of …, 2004 - Elsevier